How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?

How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?

Abstract Background The popularity of multigene testing increases the probability of identifying variants of uncertain significance (VUS). While accurate variant interpretation enables clinicians to be better informed of the genetic risk of their patients, currently, there is a lack of consensus man...

Full description

Bibliographic Details
Main Authors:	Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Chun Hang Au, Tsun-Leung Chan, Edmond Shiu Kwan Ma
Format:	Article
Language:	English
Published:	BMC 2022-05-01
Series:	BMC Medical Genomics
Subjects:	Hereditary breast cancer Breast cancer risk Variants of uncertain significance
Online Access:	https://doi.org/10.1186/s12920-022-01270-4

Similar Items

Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
by: Judit Jimenez-Sainz, et al.
Published: (2021-05-01)

Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia
by: Rosado-Jiménez Laura, et al.
Published: (2023-09-01)

A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect
by: Lesa M. Dawson, et al.
Published: (2020-02-01)

Functional Analyses of Rare Germline Missense <i>BRCA1</i> Variants Located within and outside Protein Domains with Known Functions
by: Henrikke Nilsen Hovland, et al.
Published: (2023-01-01)

A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes
by: Sukh Makhnoon, et al.
Published: (2023-02-01)

Germline mutations in Chinese ovarian cancer with or without breast cancer
by: Ava Kwong, et al.
Published: (2022-07-01)

Missense Variants of Uncertain Significance: A Powerful Genetic Tool for Function Discovery with Clinical Implications
by: Gaetana Sessa, et al.
Published: (2021-07-01)

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
by: Ava Kwong, et al.
Published: (2020-11-01)

Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients
by: Rebeca Silveira Grasel, et al.
Published: (2020-10-01)

Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives
by: Hikmat Abdel-Razeq, et al.
Published: (2022-03-01)

A Case Report of Germline Compound Heterozygous Mutations in the <i>BRCA1</i> Gene of an Ovarian and Breast Cancer Patient
by: Ava Kwong, et al.
Published: (2021-01-01)

Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?
by: Roberta Zuntini, et al.
Published: (2021-05-01)

Genetic testing for breast cancer risk, from BRCA1/2 to a seven gene panel: an ethical analysis
by: Erik Gustavsson, et al.
Published: (2020-10-01)

Germline <i>PALB2</i> Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
by: Ava Kwong, et al.
Published: (2021-08-01)

Germline Missense Variants in <i>BRCA1</i>: New Trends and Challenges for Clinical Annotation
by: Volha A. Golubeva, et al.
Published: (2019-04-01)

Surgical Management of Hereditary Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01)

Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer
by: Thais Baccili Cury Megid, et al.
Published: (2022-08-01)

Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer
by: Kawmadi Gunawardena, et al.
Published: (2023-06-01)

Clinical and genetic characterization of hereditary breast cancer in a Chinese population
by: Wenjing Jian, et al.
Published: (2017-10-01)

Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria
by: Ava Kwong, et al.
Published: (2023-05-01)

Genetic and Preventive Services for Hereditary Breast and Ovarian Cancer in the Czech Republic
by: Foretova Lenka, et al.
Published: (2006-11-01)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
by: Daniele Fanale, et al.
Published: (2021-06-01)

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
by: Frontiers Production Office
Published: (2022-05-01)

Exploring the Relationship Between Tamoxifen and Hereditary Angioedema
by: Ana Raquel Pinto, et al.
Published: (2024-01-01)

Hereditary breast cancer: present status of problem
by: F. S. Gatueva, et al.
Published: (2020-05-01)

Clinical Outcome of Hereditary Breast Cancer in the Lithuanian Population
by: Elsakov Pavel, et al.
Published: (2005-04-01)

Whole-Exome Sequencing of Germline Variants in Non-<i>BRCA</i> Families with Hereditary Breast Cancer
by: Yaxuan Liu, et al.
Published: (2022-04-01)

Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk—Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland
by: Tadeusz Kałużewski, et al.
Published: (2023-08-01)

Pathology of Hereditary Breast and Ovarian Cancer
by: Anjelica Hodgson, et al.
Published: (2020-09-01)

BRCA Previvors: Medical and Social Factors That Differentiate Them From Previvors With Other Hereditary Cancers
by: Campo-Engelstein, Lisa
Published: (2017-04-01)

Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
by: Dudaladava Volha, et al.
Published: (2006-01-01)

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the <i>BRCA1</i> and <i>BRCA2</i> Genes
by: Laura Caleca, et al.
Published: (2019-01-01)

Uncovering the clinical relevance of unclassified variants in DNA repair genes: a focus on BRCA negative Tunisian cancer families
by: Maroua Boujemaa, et al.
Published: (2024-01-01)

Thymidylate synthase gene (<it>TYMS</it>) polymorphisms in sporadic and hereditary breast cancer
by: Junior José da Silva Nogueira, et al.
Published: (2012-12-01)

Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer
by: Eliza Del Fiol Manna, et al.
Published: (2023-08-01)

Associations of pathogenic mutations responsible for breast cancer risk with histology and immunohistochemistry in Romanian population
by: Goidescu Iulian Gabriel, et al.
Published: (2018-04-01)

Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
by: Pavlina Chrysafi, et al.
Published: (2023-12-01)

Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
by: Elisa De Paolis, et al.
Published: (2023-01-01)

Histological and Immunohistochemical Characteristics for Hereditary Breast Cancer Risk in a Cohort of Brazilian Women
by: Renata Mendes de Freitas, et al.
Published: (2022-10-01)

Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
by: Juliana Batista de Moura, et al.
Published: (2021-11-01)